3 ms·
If that were actually the case, Europe should've had a huge competitive advantage in drug development and priced the majority American drug companies out of bus
by kenhwang 6y ago
If that were actually the case, Europe should've had a huge competitive advantage in drug development and priced the majority American drug companies out of business. Isn't anywhere close to happening, is it?
- danaris 6y agoThe barrier to entry to the pharmaceutical business is fairly high. Not only is it a pretty heavily regulated field (for damn good reasons), the equipment needed to start a drug company is significant and expensive, and the time between first investment and first payoff can be very long.
- flumpcakes 6y agoVarious reasons, including patents. Cost is not a "huge competetive advantage" or literally everything would be produced by other countries with fewer regulations for cheaper. There's plently of protected industries in nearly every country.